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Background

Results

Venous Thromboembolism (VTE) is a disease of
deep venous thrombus formation, including deep
venous thromboembolism (DVT) and pulmonary
embolism (PE), which can potentially devastate
regular pulmonary function resulting in morbidity and
mortality. VTE can increase health care costs from
additional care and longer hospital stays. It is the
most common preventable cause of hospital related
death and the third most common cause of hospitalrelated death overall. Though largely preventable,
many patients may not receive prophylaxis for VTE.
Nurses at Lehigh Valley Hospital (LVH) floor CC7C
reported that patient refusal is a major obstacle to
keeping patients on prophylactic measures. Other
studies concur this is a main reason patients do not
receive prophylaxis. Floor CC4KS has recognized this
issue previously, and uses a Standard Refusal of Care
Waiver to impress patients with the importance of
prophylaxis and as an opportunity to educate patients.
Thus, to curb patient refusal of VTE prophylaxis on
floor CC7C, we propose to intervene using a process
designed around the Standard Refusal of Care Waiver.

By manually logged data, 6 total patients out of an estimated 24 opted to discontinue prophylaxis
and sign the waiver after being further educated by physicians, giving a 75% compliance
rate with this process. Of the patients who continued to refuse, 1 opted out of anticoagulation
medication while 5 opted out of SCD use. By chart review, 51 total patients over 3 months
had logged refusals, giving an average of 17 per month compared to the September baseline
of 9 refusals. An average of 6 patients opted out of anticoagulant medication per month and
12 refused SCDs per month, compared to 7 patients refusing anticoagulant medication and 2
refusing SCDs in September.

Problem Statement
The nursing staff of floor CC7C currently does not
have a standard process for handling patient refusal of
VTE prophylaxis.

Methods
This is a prospective trial examining VTE refusal rates
after introduction of a novel intervention over a 3
month period from October to December 2015. To
start, VTE rates of all floors of LVH were examined.
Two floors (CC7C & CC4KS) with high risk patients
but differing VTE rates were chosen. VTE prevention
processes from each floor were obtained by interview.
One intervention was chosen from CC4KS to be
piloted on CC7C. Nurses on CC7C received education
on VTE and the intervention during September.
Beginning in October, patients who refused
prophylaxis were educated about VTE and then asked
to sign a Standard Refusal of Care Waiver if they
continued to refuse. Refusals were logged manually
by the nursing director. A separate chart review was
used to correlate charted refusals. September was
used as a baseline, with Oct-Dec being assessed
for improvement with intervention. VTE rates were
obtained through the LVH VTE Committee for that time
period.

Appendix 1: Main Outcome Figures from Chart Review
# Patients w/
Refusal

# Patients w/
Hold

# Total
Refusals

# Total Holds

% Refusal/
Holds

September

9

23

19

51

36%

October

13

24

34

59

58%

November

10

22

42

75

56%

December

25

40

116

156

74%

Table 1. General Chart Review. Patients with Refusal denotes the number of patients who had at least 1 refusal during hospitalization. Patients with
Hold denotes the number of patients who had at least 1 prophylactic measure (medication or SCDs) held for any reason during hospitalization. Total
Refusals includes the number of times that patients refused a prophylactic measure. Total Holds denotes the number of times that patients had a
prophylactic measure held for any reason, and includes refusals.
*Total Refusals and Total Holds may be multiple per patient depending on how many times prophylaxis was refused or held. Measures include both
medication and SCDs. SCDs were considered held if charted ‘off’ without a reason.
# Patients Refused
AC Med

# Patients Refused
SCD

# Total AC Med
Refusals

# Total SCD
Refusals

September

7

2

16

3

October

5

10

8

26

November

5

4

18

24

December

9

21

34

82

Table 2. Specific Chart Review. Patients Refused AC Med denotes the number of patients who refused at least 1 anticoagulant medication during
hospitalization. Patients Refused SCD denotes the number of patients who refused to wear SCDs at least 1 time during hospitalization (as charted).
Total AC Med Refusals denotes the total number of times an anticoagulant medication was held. Total SCD Refusals denotes the total number of times
SCDs were refused by patients.
*Total AC Med and Total SCD Refusals may be multiple per patient depending on how many times a patient refused prophylaxis.

Appendix 2: Main Outcomes from Manually Logged Data
# Patients Refused SCDs

# Patients Refused AC Meds

# Patients Presented Form

5

1

24

Success Rate of Intervention by Manual Data

18/24 = 75%

Table 3. Manually Logged Data. Out of the 24 patients confronted with the intervention, 18 chose to continue prophylaxis. Of those who refused, 5
refused to wear SCDs and 1 refused anticoagulant medication.

Conclusion
Manually logged data and reports from nursing director show that using a Standard Refusal of
Care Waiver can be an effective deterrent to patient refusal of VTE prophylaxis. When patients
were educated about VTE and presented the form, they tended to accept prophylaxis. However,
the charted data that shows an insignificant change to the number of refusals, specifically
concerning anticoagulant medication. Overall, this process is likely effective in deterring refusals
but needs refinement in implementation before improvement can be shown.
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